novo nordisk semaglutide clinical trials FLOW Trial (funded by Nordisk): showed 24% reduction in the risk of kidney disease-related events in people with type 2 diabetes and chronic kidney disease compared to placebo. Investigators Two-year effects of semaglutide in
Description
Do GLP-1 boosting supplements work
When Stress Becomes a Health Concern While short-term stress is a normal part of life and can even be beneficial in certain situations, chronic stress can lead to serious health consequences due to prolonged elevations in cortisol
Balducci, E
Rationale for selection : Immune dysregulation and vascular dysfunction may contribute to the pathogenesis of Long COVID
Thats why we never offered compounded GLP-1s, even when the demand was skyrocketing and other pharmacies were jumping on the bandwagon
